Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States

TAIPEI, Taiwan, Oct. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClose... Devices, Surgery Medeon Biodesign, AbClose, laparoscopy, port site wound closure

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043093

Source: HSMN NewsFeed - October 20, 2017 Category: Pharmaceuticals Source Type: news